BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18196995)

  • 1. Therapy and clinical trials: diabetes and cardiovascular risk.
    Peter R
    Curr Opin Lipidol; 2008 Feb; 19(1):101-3. PubMed ID: 18196995
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing cardiovascular risk in patients with type 2 diabetes mellitus.
    Nicholls SJ; Rydén L
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S1. PubMed ID: 20489414
    [No Abstract]   [Full Text] [Related]  

  • 3. Reducing cardiovascular disease risk in patients with type 2 diabetes: a message from the National Diabetes Education Program.
    Gavin JR; Peterson K; Warren-Boulton E;
    Am Fam Physician; 2003 Oct; 68(8):1569-74. PubMed ID: 14596445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
    Peter R; Reilly E; Anthony S
    Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
    [No Abstract]   [Full Text] [Related]  

  • 5. [How to defuse the diabetes mellitus time bomb: identify early signs and vascular injuries, minimize risk factors].
    Janka HU
    MMW Fortschr Med; 2003 May; 145(21):29-30. PubMed ID: 12845863
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategies to improve diabetes care.
    Bodenheimer T
    Am Fam Physician; 2003 Oct; 68(8):1500, 1503-4, 1506. PubMed ID: 14596438
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus: can it offer both cardiovascular protection and beta-cell preservation?
    Gerstein HC; Rosenstock J
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):137-54. PubMed ID: 15752926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy and clinical trials.
    Usman M; Peter R
    Curr Opin Lipidol; 2006 Oct; 17(5):612-4. PubMed ID: 16960511
    [No Abstract]   [Full Text] [Related]  

  • 9. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation.
    Franjic B; Marwick TH
    J Hum Hypertens; 2009 Nov; 23(11):709-17. PubMed ID: 19516273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes and hypertension. Results from the ADVANCE study].
    Mehlsen J
    Ugeskr Laeger; 2008 Feb; 170(7):531-2. PubMed ID: 18291082
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trends in diabetes].
    Ruiz J; Egli M
    Rev Med Suisse; 2008 Jan; 4(140):116, 118-21. PubMed ID: 18309874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does intensive glycemic control improve cardiovascular outcomes?
    Pendergrass M
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical factors that influence the cardiovascular morbidity in patients with type II diabetes mellitus.
    Kyriazis I; Mendrinos D; Saridi M
    Eur J Intern Med; 2010 Apr; 21(2):e9. PubMed ID: 20206869
    [No Abstract]   [Full Text] [Related]  

  • 17. Earlier treatment may explain diabetes data.
    Abbey DM
    Science; 2009 Feb; 323(5917):1009. PubMed ID: 19229018
    [No Abstract]   [Full Text] [Related]  

  • 18. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 19. Moderate exercise reduces the risk of heart disease and death in men with type 2 diabetes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jun; 14(11):10, 12. PubMed ID: 12877117
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.